USANA Health Sciences, Inc.

NYSE:USNA Rapporto sulle azioni

Cap. di mercato: US$760.9m

USANA Health Sciences Gestione

Gestione criteri di controllo 3/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Jim Brown

Amministratore delegato

US$2.5m

Compenso totale

Percentuale dello stipendio del CEO28.7%
Mandato del CEO8yrs
Proprietà del CEOn/a
Durata media del management7.8yrs
Durata media del Consiglio di amministrazione6.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Sep 26
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?

Sep 08
Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?

USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 26
USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding

Jul 17
There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding

USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively

May 29
USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively

USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 03
USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?

May 01
Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares

Apr 04
USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares

USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Feb 08
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

Jan 06
Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation

Oct 23

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Sep 09
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

Jul 27
Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

USANA Earnings Preview: From China's Challenge To India's Promise

Jul 21

USANA Health Sciences says Brown will transition to CEO in July 2023

Feb 13

Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

Feb 02
Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates

Oct 25

Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Oct 18
Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Jul 22
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Jul 07
Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Jun 14
Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Jim Brown rispetto agli utili di USANA Health Sciences?
DataCompenso totaleStipendioGuadagni aziendali
Sep 28 2024n/an/a

US$54m

Jun 29 2024n/an/a

US$55m

Mar 30 2024n/an/a

US$62m

Dec 30 2023US$2mUS$710k

US$64m

Sep 30 2023n/an/a

US$60m

Jul 01 2023n/an/a

US$63m

Apr 01 2023n/an/a

US$65m

Dec 31 2022US$2mUS$624k

US$69m

Oct 01 2022n/an/a

US$77m

Jul 02 2022n/an/a

US$89m

Apr 02 2022n/an/a

US$108m

Jan 01 2022US$2mUS$600k

US$117m

Oct 02 2021n/an/a

US$136m

Jul 03 2021n/an/a

US$139m

Apr 03 2021n/an/a

US$129m

Jan 02 2021US$2mUS$599k

US$125m

Sep 26 2020n/an/a

US$116m

Jun 27 2020n/an/a

US$110m

Mar 28 2020n/an/a

US$103m

Dec 28 2019US$2mUS$559k

US$101m

Sep 28 2019n/an/a

US$102m

Jun 29 2019n/an/a

US$109m

Mar 30 2019n/an/a

US$121m

Dec 29 2018US$2mUS$534k

US$126m

Sep 29 2018n/an/a

US$88m

Jun 30 2018n/an/a

US$81m

Mar 31 2018n/an/a

US$70m

Dec 30 2017US$1mUS$523k

US$63m

Compensazione vs Mercato: La retribuzione totale di Jim ($USD 2.47M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 3.18M ).

Compensazione vs guadagni: La retribuzione di Jim è aumentata di oltre il 20%, mentre gli utili aziendali sono diminuiti di oltre il 20% nell'ultimo anno.


AMMINISTRATORE DELEGATO

Jim Brown (55 yo)

8yrs

Mandato

US$2,472,017

Compensazione

Mr. Jim Brown has been the President of USANA Health Sciences Inc. since November 2016 and served as its Chief Operating Officer since November 2013 until October 2019. He serves as Chief Executive Officer...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Kevin Guest
Executive Chairman7.5yrsUS$3.91m0.064%
$ 486.1k
Jim Brown
CEO & President8yrsUS$2.47mNessun dato
G. Hekking
Chief Financial Officer7.5yrsUS$1.47mNessun dato
Walter Noot
Chief Operating Officer5.1yrsUS$1.42mNessun dato
P. Foukas
Chief Legal Officer6.3yrsUS$1.29mNessun dato
Daniel Macuga
Chief Communications & Marketing Officer12.9yrsUS$1.15mNessun dato
Myron Wentz
Founder & Chairman Emeritus32.8yrsNessun dato40.62%
$ 309.0m
John Cuomo
Executive Director of Product Development & Technology11.9yrsNessun datoNessun dato
Robert Sinnott
Chief Scientific Officer8.3yrsNessun datoNessun dato
Peter Benedict
Chief Information Officerno dataNessun datoNessun dato
Patrique Richards
Executive Director of Investor Relations & Business Developmentno dataNessun datoNessun dato
Paul Jones
Chief People Officer3.8yrsUS$637.78k0%
$ 0

7.8yrs

Durata media

58yo

Età media

Gestione esperta: Il team dirigenziale di USNA è esperto e expertise (durata media dell'incarico 7.8 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Kevin Guest
Executive Chairman7.5yrsUS$3.91m0.064%
$ 486.1k
Myron Wentz
Founder & Chairman Emeritus4.5yrsNessun dato40.62%
$ 309.0m
Gilbert Fuller
Lead Independent Director16.2yrsUS$251.60kNessun dato
Peggie Pelosi
Independent Director5.9yrsUS$231.40k0.021%
$ 156.6k
Timothy Wood
Independent Director5.1yrsUS$218.40k0.034%
$ 256.8k
Christine Wood
Member of Scientific Advisory Councilno dataNessun datoNessun dato
Monica Lewis
Member of Scientific Advisory Councilno dataNessun datoNessun dato
Peter Rugg
Chairperson of Scientific Advisory Council20.8yrsNessun datoNessun dato
Bart Moore
Member of Scientific Advisory Councilno dataNessun datoNessun dato
Heather Tick
Member of Scientific Advisory Councilno dataNessun datoNessun dato
Frederic Winssinger
Independent Director8.5yrsUS$233.60k0.024%
$ 180.6k
J. Nixon
Independent Director2.3yrsUS$218.40k0.022%
$ 169.1k

6.7yrs

Durata media

68yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di USNA sono considerati esperti (durata media dell'incarico 6.7 anni).